| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 17 |
| 1 | PAZOPANIB HYDROCHLORIDE | 14 |
| 2 | CABOZANTINIB | 13 |
| 3 | ASPIRIN | 9 |
| 4 | ASPIRIN 325 MG | 9 |
| 5 | ASPIRIN 81 MG | 9 |
| 6 | ACETAMINOPHEN | 8 |
| 7 | ACETAMINOPHEN 500MG | 7 |
| 8 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 7 |
| 9 | AXITINIB | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAMPHOR, MENTHOL, METHYL SALICYLATE | 1 | 0.0204 |
| 1 | 1.1% SODIUM FLUORIDE PRESCRIPTION DENTAL CREAM | 2 | 0.0120 |
| 2 | L-ARGININE | 1 | 0.0028 |
| 3 | TIVOZANIB | 3 | 0.0019 |
| 4 | PIOGLITAZONE HYDROCHLORIDE | 1 | 0.0008 |
| 5 | EPCORITAMAB-BYSP | 1 | 0.0007 |
| 6 | LIDOCAINE AND PRILOCAINE | 1 | 0.0007 |
| 7 | BACILLUS CALMETTE-GUERIN | 1 | 0.0006 |
| 8 | MITOMYCIN | 2 | 0.0005 |
| 9 | PAZOPANIB HYDROCHLORIDE | 14 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 1 | Actinomycin [EPC] | 1 | 0.0005 |
| 2 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 3 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 22 | 0.0002 |
| 5 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 6 | Chloride Channel Activator [EPC] | 2 | 0.0002 |
| 7 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 8 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 9 | Glinide [EPC] | 1 | 0.0001 |